Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer. [electronic resource]
Producer: 19970311Description: 891-902 p. digitalISSN:- 1079-9907
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Survival -- drug effects
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Humans
- Immunologic Factors -- pharmacology
- Interferon-beta -- adverse effects
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Radiation-Sensitizing Agents -- therapeutic use
- Recombinant Proteins -- therapeutic use
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.